MUNICH, Dec. 18, 2020 /PRNewswire/ -- Garching - OncoBeta® GmbH and their subsidiary OncoBeta Therapeutics Pty Ltd. Australia a Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanoma Skin Cancers (NMSCs), announced today that the Rhenium-SCT...
from PR Newswire: https://ift.tt/3nA1vV5
No comments:
Post a Comment